SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

HPE is trending as investors react to a significant government contract win for data center modernization, while the market weighs its competitive standing against server peers in the ongoing AI infrastructure cycle. Community sentiment remains focused on the company's valuation, potential margin improvements from the Juniper integration, and whether upcoming earnings will reveal stronger AI demand.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors monitor ongoing clinical trials and the upcoming late-year FDA decision for ivonescimab, while debating the significance of recent data readouts. The community is actively tracking the stock's potential for institutional interest and acquisition rumors, often drawing comparisons to other high-profile oncology competitors.

NXP Semiconductors NV is a holding company which engages in the provision of semiconductor solutions. It operates through the following geographical segments: China, Netherlands, United States, Singapore, Germany, Japan, South Korea, Malaysia, and Other Countries. The company was founded on August 2, 2006, and is headquartered in Eindhoven, the Netherlands.

NXP Semiconductors NV

NXP Semiconductors is trending as the semiconductor sector focuses on AI-driven data center infrastructure and automotive silicon, with investors closely watching the company's position within the global AI hardware supply chain. The community is actively discussing its technical breakout, institutional sentiment, and the company's expanding role in secure connectivity and industrial automation as market participants look for opportunities beyond mega-cap stocks.

REX ETF Trust - REX Drone ETF

REX Drone ETF

The REX Drone ETF is capturing investor interest as a thematic vehicle for betting on the expansion of autonomous defense systems and domestic drone manufacturing. Community discussions center on the ETF's concentrated exposure to key industry players and its potential to capture long-term growth driven by increased government defense contracts and commercial drone adoption.

Gladstone Investment Corp., a traded business development company, which engages in the provision of lower middle market companies located in the United States. The fund focuses on companies with an EBITDA of USD 4 - 15 million. It targets companies operating in the fields of manufacturing, consumer products and business and consumer services. It provides financing for debt, buyout and growth stage capital requirements with an investment size up to USD 75 million. The company was founded in 2005 and is headquartered in McLean, VA.

Gladstone Investment Corporation

Gladstone Investment (GAIN) is trending as investors debate the impact of the viral NeeDoh toy craze on the company's portfolio performance and potential for future supplemental dividends. While some shareholders are taking profits amid recent share price volatility, others are emphasizing the company's consistent monthly payouts and strong, debt-free portfolio quality as a margin of safety.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending following reports that merger discussions with Merck have ended due to valuation disagreements, causing a significant shift in investor sentiment toward the biotech firm. The market is now closely analyzing the company's long-term potential as an independent oncology player versus the likelihood of future interest from other strategic bidders.

ETF Series Solutions - Defiance Drone and Modern Warfare ETF

Drone & Modern Warfare ETF

The JEDI ETF is attracting significant investor interest as rising geopolitical tensions and potential government funding for domestic drone manufacturing fuel a broader surge in the aerospace and defense sector. Community members are actively discussing the fund as a strategic, wide-net alternative to picking individual stock winners in the rapidly evolving landscape of modern, AI-driven warfare technology.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending due to a significant partnership with the DTCC, which plans to integrate its tokenization platform with the Stellar network to handle institutional-grade securities. The community is actively debating the token's long-term utility and potential price appreciation as it aligns with real-world financial infrastructure, despite skepticism regarding short-term volatility.

Zoracles

Zoracles is attracting significant community attention as investors debate its role within the Base ecosystem and the broader creator economy. Sentiment remains polarized, with many users actively discussing the potential for a rebound driven by upcoming regulatory catalysts while others express frustration over recent price volatility.

Bubble Protocol (BPL) is the utility token powering the BubbleSwap ecosystem on Shido Network.  BPL is designed to reduce trading fees, reward long-term holders through staking, and provide access to ecosystem opportunities such as BubblePad airdrops.  With a fixed supply of 20M tokens and a buyback &amp; burn mechanism tied to protocol activity, BPL is built around real usage and growth, not speculation.

Bubble Protocol

Bubble Protocol is gaining momentum as investors highlight its expanding suite of DeFi tools on the Shido Network, including a new gasless smart account feature and automated token-burning mechanics. The community is actively discussing the project's ecosystem growth and its recent listings on major data platforms as they look for long-term utility within the Shido infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates

Standard BioTools (LAB) delivered earnings and revenue surprises of 0.00% and +13.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Beats Expectations By $0.35 EPS

Standard BioTools (NASDAQ:LAB - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus...

Standard BioTools Inc. (NASDAQ:LAB) Sees Significant Drop in Short Interest

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 8,479,342 shares, a decline of 17.8% from the March 31st total of 10,319,954 shares. Based on an average daily...

Standard BioTools (LAB) Projected to Post Earnings on Tuesday

Standard BioTools (NASDAQ:LAB) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...

Standard BioTools Inc. (NASDAQ:LAB) Sees Large Growth in Short Interest

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 10,319,954 shares, a growth of 24.6% from the March 15th total of 8,281,198 shares. Currently, 3.4% of the...

Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Declines By 18.5%

Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the recipient of a significant drop in short interest in March. As of March 13th, there was short interest totaling 8,281,198 shares, a drop of 18.5% from the February 26th total of 10,159,609 shares. Approximately 2.8% of the shares of the...

Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Standard BioTools from a "sell" rating to a "hold" rating in a report on Saturday...

Standard BioTools Inc. $LAB Shares Purchased by Mak Capital One LLC

Mak Capital One LLC grew its position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 184.6% during the third quarter, according to its most recent Form 13F filing with the...

Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen

Wall Street Zen cut shares of Standard BioTools from a "hold" rating to a "sell" rating in a report on Sunday...

Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Standard BioTools from a "sell" rating to a "hold" rating in a research note on Saturday...

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.

LAB
Standard BioTools Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest LAB News

LABStandard BioTools Inc